Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000207

Drug Information
NameMarinol
Synonyms1-trans-.delta.(sup9)-tetrahydrocannabinol; (-)-trans-delta9-Tetrahydrocannabinol; T4764_SIGMA; PDSP2_000714; L-trans-.delta.9-Tetrahydrocannabinol; T4764_FLUKA; 9-delta-Tetrahydrocannabinol; Cannabinol, tetrahydro- (6CI); nchembio.552-comp1; delta(sup 9)-Tetrahydrocannabinol; 6465-30-1; (-)-trans-Delta1-Tetrahydrocannabinol; Cannabis resin; (-)-trans-.DELTA.9-Tetrahydrocannabinol; delta1-Tetrahydrocannabinol; nchembio.86-comp3; QCD 84924; NSC 134454; 14C-.DELTA.1-Tetrahydrocannabinol; trans-.DELTA.9-Tetrahydrocannabinol; DRG-0138; QCD-84924; .DELTA.9-THC; CCRIS 4726; trans-delta9-Tetrahydrocannabinol; Omegaven; delta9-Tetrahydrocannabinol (VAN); Fats and Glyceridic oils, fish, n-3 fatty acid-high; LS-975; Cannabinol, 1-trans-delta(sup 9)-tetrahydro-; ZINC01530625; (-)-3,4-trans-Delta1-Tetrahydrocannabinol; delta-9-tetrahydrocannabinol; delta(sup 1)-Thc; (-)-.DELTA.9-THC; delta9-THC; trans-delta-9-Tetrahydrocannabinol; MolPort-003-959-698; (L)-.delta.1-Tetrahydrocannabinol; (-)-.DELTA.1-Tetrahydrocannabinol; 308064-99-5; delta(9)-THC; EPA 28; 1-trans-delta9-Tetrahydrocannabinol; Cannabinol, Delta1-tetrahydro- (7CI); delta(1)-Tetrahydrocannabinol; Abbott 40566; delta(sup 9)-Thc; CHEBI:104496; (-)-delta9-(trans)-Tetrahydrocannabinol; Cannabinol, .DELTA.1-tetrahydro-; Sonergx; L-.delta.1-trans-Tetrahydrocannabinol; 1972-08-3; CAT-310; Marinol (TN); (-)-delta1-Tetrahydrocannabinol; Marinol; L-trans-delta9-Tetrahydrocannabinol; D00306; EPA-PLUS; Tetranabinex; 5957-27-7; Dronabinolum; delta(sup 1)-Tetrahydrocannabinol; SP 104; delta(1)-THC; Deltanyne; 9-tetrahydrocannabinol; 14146-43-1; (-)-delta9-Tetrahydrocannabinol; Dronabinolum [Latin]; (-)-delta9-trans-Tetrahydrocannabinol; Fish oils, n-3 fatty acid-high; THC-delta-9; Delta9-Tetrahydrocannabinol solution; (-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol; THC; delta9-Tetrahydrocannabinol; nchembio.129-comp1; delta9-trans-Tetrahydrocannabinol; 1-trans-delta(sup9)-tetrahydrocannabinol; trans-tetrahydrocannabinol; AC1L277U; Ganja; Dronabinol (USP/INN); (l)-delta1-Tetrahydrocannabinol; .DELTA.1-Tetrahydrocannabinol; delta1-Tetrahydrocannabinol (VAN); 9-ene-Tetrahydrocannabinol; Drona binol; Dronabinol; UNII-7J8897W37S; Cannabinol, 1-trans-.delta.(sup9)-tetrahydro-; 1-trans-D9-Tetrahydrocannabinol; AC1Q2VRZ; MaxEPA; .DELTA.1-THC; T2386_SIGMA; Hashish; Dronabinol [USAN:INN]; BIDD:GT0427; Cannabinol, delta1-tetrahydro-; Tetrahydrocannabinols (-)-delta1-3,4-trans-form; delta(9)-Tetrahydrocannabinol; L-delta1-trans-Tetrahydrocannabinol; CHEMBL465; L-delta(sup 1)-tetrahydrocannabinol; Marincap; delta1-THC; (-)-.DELTA.9-Tetrahydrocannabinol; (-)-.delta.(sup9)-trans-Tetrahydrocannabinol; .delta.-9-THC; TETRAHYDROCANNABINOL; DEA No. 7370; Namisol; NSC134454; Tetrahydrocannabinol delta9; Relivar; DB00470; Fish oils, omega-3 fatty acid-high; 1-trans-delta-9-Tetrahydrocannabinol; C06972; DEA No. 7369; delta-9-THC; .DELTA.9-trans-Tetrahydrocannabinol; L-.delta.1-Tetrahydrocannabinol; Compassia; CID16078; (l)-delta(sup 1)-Tetrahydrocannabinol; (-)-.DELTA.9-trans-Tetrahydrocannabinol; 26108-45-2; Pro-Mega; HSDB 6471; .delta.(sup9)-THC; delta-THC; 1363-19-5; omega-3-Fatty acid; 6H-Dibenzo; Promega; delta(9)-Tetrahydrocannibinol; 1-trans-delta(sup 9)-Tetrahydrocannabinol; (-)-trans-Delta9-THC; 14146-29-3
CompanyUnimed Pharmaceuticals
IndicationAnorexia
[ICD9: 307.1   ICD10: F50.0-F50.1]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,
4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1
InChIKeyCYQFCXCEBYINGO-IAGOWNOFSA-N
Canonical SMILESCCCCCC1=CC2=C(C3C=C(CCC3C(O2)(C)C)C)C(=C1)O    
Isomeric SMILESCCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)O
Therapeutic ClassAnalgesics
CAS NumberCAS 1972-08-3
FormulaC21H30O2
PubChem Compound IDCID 16078.
PubChem Substance IDSID 9186.
SuperDrug ATC IDA04AD10
SuperDrug CAS ID001972083;
TargetCannabinoid receptor 1Agonist[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 018651 To Reference
Ref 2Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol. 2009 Feb;156(3):397-411. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543